Recap: Emergent BioSolutions Q2 Earnings

Emergent BioSolutions EBS reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Emergent BioSolutions missed estimated earnings by 332.43%, reporting an EPS of $-0.86 versus an estimate of $0.37.

Revenue was down $154.80 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 11.55% drop in the share price the next day.

Here's a look at Emergent BioSolutions's past performance:

To track all earnings releases for Emergent BioSolutions visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.